Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OncoAlert and ecancer round up: SABCS 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer round up: SABCS 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with...

Prof Meral Beksac and Prof Roman Hájek

INTEGRATE study: Treatment pathways, outcomes and resource use in patients with multiple myeloma ( Prof Meral Beksac and Prof Roman Hájek )

Silver linings: a qualitative study of desirable changes to cancer care during...

Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe...

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic ( Prof Richard Sullivan - Kings College London, London, UK & Dr Dorothy Lombe - Regional Cancer Treatment Service, Palmerston North, New Zealand )

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first...

Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands

Glow study: MRD outcomes after fixed-duration Ibr+Ven versus Clb+O for first-line treatment of CLL in elderly or unfit patients ( Dr Arnon Kater - Amsterdam UMC, Amsterdam, Netherlands )

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for...

Dr Michael Bishop - University of Chicago, Chicago, USA

Tisagenlecleucel shows no EFS improvement on standard of care in 2L for aggressive B-cell NHL ( Dr Michael Bishop - University of Chicago, Chicago, USA )

Integrated genomic analysis identifies UBTF tandem duplications as a subtype...

Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA

Integrated genomic analysis identifies UBTF tandem duplications as a subtype-defining lesion in paediatric AML ( Dr Masayuki Umeda - St. Jude Children's Research Hospital, San Francisco, USA )

Asciminib found to be safe and effective for heavily pretreated patients with...

Dr Michael Mauro - Memorial Sloan Kettering Cancer Center, New York, USA

Asciminib found to be safe and effective for heavily pretreated patients with chronic myeloid leukaemia in chronic phase ( Dr Michael Mauro - Memorial Sloan Kettering Cancer Center, New York, USA )

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first...

Prof Andrew Wei - Monash University, Melbourne, Australia

Long-term OS benefit with oral azacitidine for acute myeloid leukaemia in first remission after intensive chemo ( Prof Andrew Wei - Monash University, Melbourne, Australia )

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL

Dr Ibrahim Aldoss - City of Hope, Duarte, USA

Allogeneic haematopoietic cell transplantation in adults with Ph-like ALL ( Dr Ibrahim Aldoss - City of Hope, Duarte, USA )

Azacitidine, venetoclax and gilteritinib for FLT3-mutated AML

Prof Nicholas Short - The University of Texas MD Anderson Cancer Center...

Azacitidine, venetoclax and gilteritinib for FLT3-mutated AML ( Prof Nicholas Short - The University of Texas MD Anderson Cancer Center, Houston, USA )

Ten-day decitabine with venetoclax in acute myeloid leukaemia: Updated outcomes...

Dr Abhishek Maiti - The University of Texas MD Anderson Cancer Center, Houston...

Ten-day decitabine with venetoclax in acute myeloid leukaemia: Updated outcomes across genomic subgroups ( Dr Abhishek Maiti - The University of Texas MD Anderson Cancer Center, Houston, USA )

Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory...

Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA

$Axicabtagene ciloleucel vs standard‑of‑care therapy for relapsed/refractory large B-cell lymphoma ( Dr Frederick Locke - Moffitt Cancer Centre, Tampa, USA )$

More from ecancer